Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.0350 (0.43%) ($7.0350 - $7.0350) on Fri. Jun. 23, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.86% (three month average) | RSI | 25 | Latest Price | $7.0350(0.43%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -2.6% a day on average for past five trading days. | Weekly Trend | BCRX declines -8.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) BND(27%) EWI(27%) EWJ(26%) ARKG(24%) SDY(24%) | Factors Impacting BCRX price | BCRX will decline at least -1.43% in a week (0% probabilities). VIXM(-27%) VXX(-22%) SHY(-20%) VCIT(-18%) TLT(-18%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.43% (StdDev 2.86%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-5.51(-178.32%) | Resistance Level | $8 | 5 Day Moving Average | $7.18(-2.02%) | 10 Day Moving Average | $7.65(-8.04%) | 20 Day Moving Average | $8(-12.06%) | To recent high | -20.6% | To recent low | 0.4% | Market Cap | $1.241b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |